T2 Biosystems Raises $15M in Series C Round

The molecular diagnostics startup is developing a decentralized diagnostic platform that enables rapid molecular and immunodiagnostic testing on a single instrument.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories